1 active not recruiting, 1 recruiting, 1 suspended. 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Suspended 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Ivan de Kouchkovsky, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone Abiraterone acetate, Prednisone, Hyperpolarized [1-13C] pyruvate (HP 13C) - High Risk Prostate Carcinoma, Prostate Cancer | Phase 2 | Active not recruiting | Ivan de Kouchkovsky, MD | 32 | 2024-12-09 | 2026-09-04 |
| Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer Hyperpolarized C13, Magnetic Resonance Imaging (MRI) - Prostate Cancer, Advanced Prostate Carcinoma | Phase 2 | Suspended | Ivan de Kouchkovsky, MD | 75 | 2020-07-16 | 2026-06-23 |
| Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer Hyperpolarized 13C-Pyruvate, Hyperpolarized 13C,15N2-urea, Magnetic Resonance Spectroscopic Imaging - Prostate Cancer, Localized Prostate Carcinoma | Early Phase 1 | Recruiting | Ivan de Kouchkovsky, MD | 80 | 2016-03-22 | 2026-04-30 |
Magnetic Resonance Spectroscopy (3) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Abiraterone Acetate (1) · Glutamate Carboxypeptidase II (1) · Prednisone (1) · Pyruvic Acid (1) · abiraterone (1)
United States (3)
U01EB026412 (2), R01CA211150 (1), R01CA214554 (1), R01CA215694 (1), R01CA238379 (1), R01CA300053 (1), R01EB017449 (1)